Evidence map›Paper›PMID 21862636›Full record

ArticleCancer research2011

p38γ promotes breast cancer cell motility and metastasis through regulation of RhoC GTPase, cytoskeletal architecture, and a novel leading edge behavior.

Devin T Rosenthal, Harish Iyer, Silvia Escudero, Liwei Bao, Zhifen Wu, Alejandra C Ventura, Celina G Kleer, Ellen M Arruda, Krishna Garikipati, Sofia D Merajver

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. The Role of p38γ in Cancer: From review to outlook.International journal of biological sciences · 2021
    Review
  12. Article
  13. The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells.Medical science monitor : international medical journal of experimental and clinical research · 2019
    Article
  14. Article
  15. Article
  16. Role of p38γ MAPK in regulation of EMT and cancer stem cells.Biochimica et biophysica acta. Molecular basis of disease · 2018
    Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Devin T RosenthalDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Harish Iyer
Silvia Escudero
Liwei Bao
Zhifen Wu
Alejandra C Ventura
Celina G Kleer
Ellen M Arruda
Krishna Garikipati
Sofia D Merajver
Harvard University · USDana-Farber Cancer Institute · US

Funding

CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
PREVENTION OF MAMMARY CANCER IN HER-2NEU TRANSGENIC MICER01CA077612 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MERAJVER, SOFIA DIANA · 1999 to 2007
$2.2M
NCI NIH HHS R01 CA077612NIGMS NIH HHS T32 GM007315NIGMS NIH HHS T32-GM07315
6 · The paper itself

Abstract

Understanding the molecular alterations that confer cancer cells with motile, metastatic properties is needed to improve patient survival. Here, we report that p38γ motogen-activated protein kinase regulates breast cancer cell motility and metastasis, in part, by controlling expression of the metastasis-associated small GTPase RhoC. This p38γ-RhoC regulatory connection was mediated by a novel mechanism of modulating RhoC ubiquitination. This relationship persisted across multiple cell lines and in clinical breast cancer specimens. Using a computational mechanical model based on the finite element method, we showed that p38γ-mediated cytoskeletal changes are sufficient to control cell motility. This model predicted novel dynamics of leading edge actin protrusions, which were experimentally verified and established to be closely related to cell shape and cytoskeletal morphology. Clinical relevance was supported by evidence that elevated expression of p38γ is associated with lower overall survival of patients with breast cancer. Taken together, our results offer a detailed characterization of how p38γ contributes to breast cancer progression. Herein we present a new mechanics-based analysis of cell motility, and report on the discovery of a leading edge behavior in motile cells to accommodate modified cytoskeletal architecture. In summary, these findings not only identify a novel mechanism for regulating RhoC expression but also advance p38γ as a candidate therapeutic target.

Indexed as

Cell MovementAnimalsBreast NeoplasmsComputer SimulationCytoskeletonFemaleGene Expression Regulation, NeoplasticHumansLymphatic MetastasisMiceMitogen-Activated Protein Kinase 12Models, BiologicalNeoplasm InvasivenessrhoC GTP-Binding Proteinrho GTP-Binding ProteinsMitogen-Activated Protein Kinase 12rhoC GTP-Binding ProteinRHOC protein, humanrho GTP-Binding Proteins

Identifiers

PMID21862636
PMCPMC3193559
OpenAlexW1975392513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.